Vitamin D3 is metabolized first to 25-hydroxyvitamin D and then to calcitriol, the hormonally active metabolite that binds the nuclear vitamin D receptor. VDR signaling regulates intestinal calcium transport, phosphate homeostasis, skeletal mineral metabolism, and functions in muscle and immune tissues. At 10,000 IU per softgel, accurate potency control and responsible directions are especially important because the dose exceeds the adult daily upper intake level used by U.S. nutrition authorities for routine unsupervised intake.
To ensure that Cpack Manufacturing is providing a consistent Vitamin D3 10000 IU product, the formula uses a defined high-potency cholecalciferol strength within a unit-dose softgel. Finished labels should use verified potency testing and directions appropriate to the intended market rather than treating 10,000 IU as a general daily requirement.
The main benefits provided by our Private Label Vitamin D3 10000 IU supplements are as follows:
- Vitamin D3 10,000 IU — Cholecalciferol supplied at a defined 10,000 IU strength for high-potency vitamin D positioning.
- 25-Hydroxyvitamin D — Hepatic hydroxylation converts vitamin D3 to 25-hydroxyvitamin D, the primary circulating marker used to assess vitamin D status.
- Calcitriol — Renal and extra-renal hydroxylation can produce 1,25-dihydroxyvitamin D, the active hormone that binds the vitamin D receptor.
- Vitamin D Receptor — VDR is a nuclear transcription factor that regulates genes involved in calcium and phosphate transport and broader tissue functions.
- Calcium & Phosphate Homeostasis — Vitamin D signaling supports intestinal mineral absorption and coordinates with endocrine regulators to maintain skeletal mineral balance.
- High-Potency Control — A 10,000 IU unit dose requires accurate potency verification and careful finished-label directions because it is a concentrated vitamin D strength.